MedPath

acosamide for treatment-resistant bipolar disorder: a open-label study

Not Applicable
Recruiting
Conditions
treatment-resistant bipolar disorder
Registration Number
JPRN-UMIN000031579
Lead Sponsor
Fujita Health University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

no neurological or systemic diseases, including disturbance of hematopoiesis no history of electroconvulsive therapy within 6 months prior to study enrollment absence of pregnancy no dependence on any addictive substances other than nicotine in the past 5 years before enrollment no suicidal ideation and suicidal attempt

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Global Impression-Severity score from baseline to endpoint (12 weeks)
Secondary Outcome Measures
NameTimeMethod
Young Mania Rating Scale, Hamilton Rating Scale for Depression, discontinuation rate, incidence of individual adverse events
© Copyright 2025. All Rights Reserved by MedPath